Loading
DNAJC12 is a co-chaperone gene that is strongly expressed in oestrogen receptor-positive (luminal) breast cancers and is used as a luminal marker. This dossier gathers the 0 products (0 approved), 0 trials, 0 pathways and 0 resistance routes in the corpus that involve it, with external identifiers so it can be joined to UniProt, ChEMBL, Open Targets and the rest of biology.
Probable co-chaperone for the folding of biopterin-dependent aromatic amino acid hydroxylases (PAH, TH, TPH1 and TPH2); expressed at high levels in brain, heart and testis (UniProt Q9UKB3).
No product in the corpus is aimed at this target yet.
No trial in the corpus names this target or one of its products.
The resistance atlas has no route that names this target.
No pathway diagram carries this target as a node.
No companion diagnostic in the registry measures this target.
No model entry for this target yet; check the cancer entries on the models page.
No open questions recorded for this target yet. Suggest one.
Query for this target: (TITLE:"DNAJC12" OR ABSTRACT:"DNAJC12" OR TITLE:"DnaJ heat shock protein family Hsp40 member C12" OR ABSTRACT:"DnaJ heat shock protein family Hsp40 member C12" OR TITLE:"JDP1" OR ABSTRACT:"JDP1") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about DNAJC12, not a curated reading list.
The dossier as machine-readable JSON: identifiers from HGNC, Ensembl, UniProt and ChEMBL, products with status, trials, pathways, hotspots, open questions and assays. The full entity record is in the open API at /api/v1/entities/dnajc12.json. Licence CC BY-NC 4.0.